Quantification of the placebo response in ulcerative colitis

Gastroenterology
A IlnyckyjC N Bernstein

Abstract

There is consistently a measurable benefit noted among placebo users in treatment trials of ulcerative colitis (UC). The aim of this study was to define the placebo response in active UC and identify study features that influence the placebo response. MEDLINE database was searched for placebo-controlled treatment studies of active UC. Data extraction was performed by two reviewers, and one separate investigator reviewed all trials and data extraction before data tabulation. Placebo remission and benefit rates were determined for clinical, endoscopic, and histological outcomes. Synthesis analysis on the weighted proportions from the different studies explored the placebo response as it related to eight study variables. Thirty-eight of 44 studies identified were included in the analysis. The clinical remission rate was 9.1% (confidence interval [CI], 6.6-11.6) and the benefit rate was 26.7% (CI, 24.1-29.2). Similar rates were observed endoscopically and histologically. The number of study visits (< or =3 vs. >3) modified placebo response as assessed by clinical benefit (P = 0.05), endoscopic remission (P = 0.02), and histological remission (P = 0.04). Other study variables were not significant placebo response modifiers. In trial...Continue Reading

Citations

Jul 16, 2008·Inflammatory Bowel Diseases·James D LewisJonas H Ellenberg
Oct 8, 2008·Breast Cancer Research and Treatment·Jill Hervik, Odd Mjåland
Jun 24, 2008·Brain : a Journal of Neurology·Barry S Oken
May 18, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Paul EnckStephan Zipfel
Apr 15, 2003·Gut·W Grant Thompson
Aug 30, 2006·Scandinavian Journal of Gastroenterology·Stefanie JoosBenno Brinkhaus
Sep 25, 2012·Gastroenterology·Geert D'HaensUNKNOWN International Organization for Inflammatory Bowel Diseases (IOIBD) and the Clinical Trial Committee Clincom of the European
Oct 6, 2012·The Journal of Sexual Medicine·Andrea Bradford
Apr 27, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Charles N Bernstein
May 18, 2010·Homeopathy : the Journal of the Faculty of Homeopathy·Marcus Z TeixeiraMílton A Martins
Nov 11, 2009·Gastroenterología y hepatología·Ignacio Marín-Jiménez
Mar 8, 2008·Gastroenterology·James D LewisUNKNOWN Rosiglitazone for Ulcerative Colitis Study Group
Nov 4, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Charles N Bernstein
May 27, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S M PatelA J Lembo
May 27, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P Enck, S Klosterhalfen
Mar 27, 2004·Alimentary Pharmacology & Therapeutics·L LangmeadD S Rampton
Mar 27, 2003·Alimentary Pharmacology & Therapeutics·A IlnyckyjC N Bernstein
Mar 19, 2003·European Journal of Clinical Investigation·P VerniaUNKNOWN Gruppo Italiano per lo Studio del Colon and del Retto
Feb 13, 2009·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P EnckS Klosterhalfen
Jul 21, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S D DornA J Lembo
Apr 25, 2007·European Journal of Pain : EJP·Ana MacedoMagí Farré
Apr 24, 2010·Alimentary Pharmacology & Therapeutics·A C Ford, P Moayyedi
Apr 1, 2010·Alimentary Pharmacology & Therapeutics·F CremoniniA J Lembo
Dec 21, 2004·Medical Hypotheses·Andrés Bendesky, Adam M Sonabend
Aug 5, 2006·Brain, Behavior, and Immunity·Gustavo Pacheco-LópezManfred Schedlowski
Jun 7, 2006·European Urology·Jules H Schagen van LeeuwenBart L H Bemelmans
Jun 5, 2004·Gastroenterology Clinics of North America·Sonia Friedman
Sep 15, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Alexander C FordWalter Reinisch
Jul 22, 2015·Nature Reviews. Gastroenterology & Hepatology·Sigrid Elsenbruch, Paul Enck
Apr 15, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Charles N Bernstein
Jan 15, 2015·Journal of Gastroenterology·Hiroto MiwaUNKNOWN Japanese Society of Gastroenterology
Dec 10, 2014·The American Journal of Gastroenterology·Charles N Bernstein
Nov 28, 2002·Alimentary Pharmacology & Therapeutics·A Hart, M A Kamm
Aug 24, 1999·Fundamental & Clinical Pharmacology·O Chassany, M Duracinský
Jan 5, 2002·The American Journal of Gastroenterology·J D LewisG D Wu
Apr 25, 2006·Inflammatory Bowel Diseases·Chinyu Su
Dec 4, 1998·Inflammatory Bowel Diseases·R J Hilsden, M J Verhoef
Oct 29, 2005·Inflammatory Bowel Diseases·Kim L IsaacsStephan R Targan
May 29, 2003·Inflammatory Bowel Diseases·Claes HallertHans Svensson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.